These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
711 related articles for article (PubMed ID: 16637463)
1. Genetic determinants of cancer coagulopathy, angiogenesis and disease progression. Rak J; Klement P; Yu J Vnitr Lek; 2006 Mar; 52 Suppl 1():135-8. PubMed ID: 16637463 [TBL] [Abstract][Full Text] [Related]
2. Tissue factor in cancer and angiogenesis: the molecular link between genetic tumor progression, tumor neovascularization, and cancer coagulopathy. Rak J; Milsom C; May L; Klement P; Yu J Semin Thromb Hemost; 2006 Feb; 32(1):54-70. PubMed ID: 16479463 [TBL] [Abstract][Full Text] [Related]
3. The role of tumor-and host-related tissue factor pools in oncogene-driven tumor progression. Milsom C; Yu J; May L; Meehan B; Magnus N; Al-Nedawi K; Luyendyk J; Weitz J; Klement P; Broze G; Mackman N; Rak J Thromb Res; 2007; 120 Suppl 2():S82-91. PubMed ID: 18023719 [TBL] [Abstract][Full Text] [Related]
4. Tissue factor and cancer stem cells: is there a linkage? Milsom C; Magnus N; Meehan B; Al-Nedawi K; Garnier D; Rak J Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2005-14. PubMed ID: 19628788 [TBL] [Abstract][Full Text] [Related]
5. Diverse roles of tissue factor-expressing cell subsets in tumor progression. Milsom C; Yu J; May L; Magnus N; Rak J Semin Thromb Hemost; 2008 Mar; 34(2):170-81. PubMed ID: 18645922 [TBL] [Abstract][Full Text] [Related]
6. Role of the tissue factor pathway in the biology of tumor initiating cells. Garnier D; Milsom C; Magnus N; Meehan B; Weitz J; Yu J; Rak J Thromb Res; 2010 Apr; 125 Suppl 2():S44-50. PubMed ID: 20434004 [TBL] [Abstract][Full Text] [Related]
8. Oncogenes as regulators of tissue factor expression in cancer: implications for tumor angiogenesis and anti-cancer therapy. Yu JL; May L; Klement P; Weitz JI; Rak J Semin Thromb Hemost; 2004 Feb; 30(1):21-30. PubMed ID: 15034795 [TBL] [Abstract][Full Text] [Related]
9. Oncogenes and tumor angiogenesis: the question of vascular "supply" and vascular "demand". Rak J; Yu JL Semin Cancer Biol; 2004 Apr; 14(2):93-104. PubMed ID: 15018893 [TBL] [Abstract][Full Text] [Related]
10. Tissue factor in tumour progression. Rak J; Milsom C; Magnus N; Yu J Best Pract Res Clin Haematol; 2009 Mar; 22(1):71-83. PubMed ID: 19285274 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of platelet function: does it offer a chance of better cancer progression control? Sierko E; Wojtukiewicz MZ Semin Thromb Hemost; 2007 Oct; 33(7):712-21. PubMed ID: 18000800 [TBL] [Abstract][Full Text] [Related]
12. Genetic pathways linking hemostasis and cancer. Garnier D; Magnus N; D'Asti E; Hashemi M; Meehan B; Milsom C; Rak J Thromb Res; 2012 Apr; 129 Suppl 1():S22-9. PubMed ID: 22682129 [TBL] [Abstract][Full Text] [Related]
13. The role of tissue factor pathway inhibitor in tumor growth and metastasis. Amirkhosravi A; Meyer T; Amaya M; Davila M; Mousa SA; Robson T; Francis JL Semin Thromb Hemost; 2007 Oct; 33(7):643-52. PubMed ID: 18000790 [TBL] [Abstract][Full Text] [Related]
15. Vascular determinants of cancer stem cell dormancy--do age and coagulation system play a role? Rak J; Milsom C; Yu J APMIS; 2008; 116(7-8):660-76. PubMed ID: 18834410 [TBL] [Abstract][Full Text] [Related]
16. Thrombin generation and the pathogenesis of cancer. Ruf W; Mueller BM Semin Thromb Hemost; 2006 Apr; 32 Suppl 1():61-8. PubMed ID: 16673267 [TBL] [Abstract][Full Text] [Related]